AAPL vs TMO: Which Is the Better Buy?
Side-by-side comparison of Apple Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Apple Inc. · Technology
$298.01
+5.8% upside to fair value
Grade B
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+7.2%).
TMO trades at a lower forward P/E
(25.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AAPL |
TMO |
| Current Price |
$298.01 |
$464.61 |
| Fair Value Estimate |
$315.38 |
$498.27 |
| Upside to Fair Value |
+5.8%
|
+7.2%
|
| Market Cap |
$4,377.0B |
$172.7B |
| Forward P/E |
36.0x
|
25.2x
|
| EV / EBITDA |
27.6x
|
19.1x
|
| Price / Sales |
9.7x
|
3.8x
|
| Price / FCF |
33.9x
|
25.6x
|
| Revenue Growth YoY |
+16.6%
|
+6.2%
|
| Gross Margin |
47.9%
|
39.4%
|
| Operating Margin |
32.6%
|
17.8%
|
| Return on Equity |
146.7%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.95%
|
3.91%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Apple Inc. is a leading technology company primarily known for its consumer electronics, including the iPhone, which remains the dominant revenue driver at approximately 51% of total sales. The company benefits from a durable competitive moat based on ecosystem lock-in, proprietary silicon, strong brand, and extensive distribution channels. Apple is currently fairly valued with a market cap of $2…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
AAPL |
TMO |
| Zone Low |
$236.53 |
$373.70 |
| Zone High |
$268.07 |
$423.53 |
| In Buy Zone? |
No
|
No
|